WASHINGTON (Reuters) – The U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices will meet next week to discuss COVID-19 booster shots, the White House said on Wednesday.
The CDC committee meeting will follow a separate meeting of a U.S. Food and Drug Administration committee this Friday and will consider for whom the use of a booster shot for the vaccine made by Pfizer Inc and BioNTech SE is appropriate.
(Reporting by Trevor Hunnicutt and Jeff Mason; Editing by Caroline Humer and Chris Reese)
